四川美豐(000731.SZ)簽署戰略合作框架協議 擬新建現代農業產業示範園項目
格隆匯5月11日丨四川美豐(000731.SZ)公佈,公司於2020年5月11日下午在德陽市旌陽區與旌陽區人民政府簽署了《現代農業產業示範園項目戰略合作框架協議》,擬在旌陽區選址新建“現代農業產業示範園項目”,
公司擬投資建設現代農業產業示範園,通過建立作物施肥模型,測土、配方、配肥,實施專人專項管理等方式,探索“減肥增效”“提升土壤肥力、改善作物品質”的新型健康農肥結合模式,搭建新型技術與農業產業橋樑,通過科學研究、試驗示範,讓公司客户能夠看得見、摸得着,切身感受到農業科技和品質肥料帶來的健康和收益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.